Shubham Upadhayay

6PUBLICATIONS
8CO-AUTHORS
PharmacogenomicsNeurology and neuromuscular diseasesMolecular targetsCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
Harnessing the neuroprotective potential of estrogen in Parkinson's disease: an insight into molecular mechanisms and therapeutic approaches.

|Mar 23, 2026
Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches.

Shubham Upadhayay

|Jul 28, 2025
Raloxifene and Fulvestrant Exert Antioxidant, Anti-Inflammatory, and Antiapoptotic Action Against Haloperidol-Induced Tardive Dyskinesia in Rats via Activation of the GPER1/PI3k/Akt/Nrf2/HO-1 Signaling Pathways.

Shubham Upadhayay, Divya Soni, Puneet Kumar

|Jul 09, 2024
Mitochondrial targeted antioxidants as potential therapy for huntington's disease.

Shubham Upadhayay, Puneet Kumar

|Nov 25, 2023
Bacillus Calmette-Guérin Vaccine Attenuates Haloperidol-Induced TD-like Behavioral and Neurochemical Alteration in Experimental Rats.

Narhari Gangaram Yedke, Shubham Upadhayay, Randhir Singh

|Jul 27, 2022
Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis.

Shubham Upadhayay, Sidharth Mehan, Aradhana Prajapati

Pageof 1

Frequent Collaborators

3 joint publications

Puneet Kumar

1 joint publications

Sidharth Mehan

1 joint publications

Aradhana Prajapati

1 joint publications

Ayat Zawawi